Skip to content
★ Sign in to follow
Optima Health plc logo

Optima Health plc Stock: price and insider trades · United Kingdom

ISIN GB00BRSCY602GB·Mcap £261.6M

1 insider bought shares over the last 90 days, the latest by 1. Jonathan Thomas 2. Andy Bones 3. Joanne Newey, filed 28 Sept 2026.

Optima Health plc: what insiders have been doing

Optima Health plc is a listed company. Filings by its managers are published through RNS (LSE). In the past year (8 November 2025 to 8 November 2026), 3 filings came from 3 insiders.

No insider sold shares on the market over the period. Instead, the filings list 3 purchases totalling €45k, made by 3 insiders. The totals exclude 2 filings filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The buyers include 2 chief executives and 1 board member. Biggest ticket of the year: €45k, bought by Julia Robertson and made public on 24 February 2026.

Across the 833 companies tracked on its exchange, the median is 6 filings; at 3 filings, this issuer sits below that mark. The full history, which starts in 2024, counts 9 purchases against no sales.

The clock since the last published purchase (28 September 2026) now reads 41 days. The median gap between a trade and its publication by RNS (LSE) is 5 days. The legal deadline for notifying a trade is three business days (UK MAR).

Every figure here comes from the filings published by RNS (LSE) and describes the past, not future prices; it is not investment advice.

Insider Decl.
9
Thresholds
n/a
Buy Volume
€196,495
9 ops. · all time
Sell Volume
n/a
n/a

Who traded when

BuySale
1. Jonathan Thomas 2. Andy Bones 3. Joanne Newey1 buy
1. Julia Robertson 2. Jonathan Thomas 3. Heidi Giles 4. Simon Arnold 5. Adam Councell 6. Joanne Newey1 buy
Jonathan Thomas1 buy
Julia Robertson1 buy

Since the insiders bought

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 20,732 of 26,912 companies
33.0
score / 100
Value
37
Quality
29
FCF yld4.5%
Earn yld0.5%
EV/EBITDA25.8x
ROE0.8%
Gross mgn29%
Net mgn1.2%
Debt/EBITDA8.2x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2026

FY ended March 2026 · cache

£2.41
Analyst consensus
4 analysts
1.25/5
£2.25Target £2.69(+12%)£3.02
Income statement
Revenue£120.6M
Gross profit£35.4M29% margin
EBITDA£15.2M13% margin
Net income£1.4M1.2% margin
Valuation
PER (trailing)120.3x
PER (forward)1354.4x
P/Book125.8x
Beta0.28
Balance sheet & cash
Market cap£261.6M
Total debt£125M
Free Cash Flow£12.1M
Debt / Equity74%
Profitability & ownership
ROE0.8%
ROA0.9%
% insiders29.2%
% institutions45.1%
Last declaration on 28 September 2026
Declarations9 total
  • ▲
    1. Chief Executive Officer 2. Chief Financial Officer 3. Chief Commercial Officer (PDMR)Executives
    0RNS
    6.561 sharesOutside a trading venueISIN GB00BRSCY602RNS:9794125
    Canonical exit: 22 Dec 2026 (T+90)
  • ▲
    1. Non-Executive Chairman 2. Chief Executive Officer 3. Chief Financial Officer 4. Non-Executive Director 5. Non-Executive Director 6. Chief Commercial Officer (PDMR)Executives
    0RNS
    51,560 sharesLondon Stock Exchange, AIM MarketRNS:e756ec52-7b33-4d08-91fd-64a729e0f50d
    Canonical exit: 22 Jul 2026 (T+90)
  • ▲
    ChairmanExecutives
    39,775 GBP15RNS
    21,500 shares@ £1.85100.0% of flowLondon Stock Exchange, AIM MarketRNS:198c3b54-d8b0-48a9-9b9d-5411ec040e31
    Canonical exit: 24 May 2026 (T+90)
  • ▲
    Chief Executive OfficerExecutives
    19,986 GBP25RNS
    13,559 shares@ £1.47431.0% of flowLondon Stock Exchange, AIM Market (XLON)RNS:5473964
    Canonical exit: 18 Mar 2025 (T+90)
  • ▲
    Non-Executive DirectorExecutives
    21,000 GBP33RNS
    12,814 shares@ £1.6388100.0% of flowLondon Stock Exchange, AIM MarketRNS:5394004
    Canonical exit: 15 Jan 2025 (T+90)
  • ▲
    Group Business Development & Propositions Director (PDMR)Executives
    19,875 GBP34RNS
    12,500 shares@ £1.59100.0% of flowLondon Stock Exchange, AIM MarketRNS:5390696-0
    Canonical exit: 12 Jan 2025 (T+90)
  • ▲
    Chief Financial OfficerExecutives
    19,992 GBP42RNS
    12,194 shares@ £1.6395100.0% of flowLondon Stock Exchange, AIM MarketRNS:5390696-1
    Canonical exit: 13 Jan 2025 (T+90)
  • ▲
    Chief Executive OfficerExecutives
    25,000 GBP26RNS
    17,618 shares@ £1.41938.2% of flowLondon Stock Exchange, AIM Market (XLON)RNS:5379817
    Canonical exit: 5 Jan 2025 (T+90)
  • ▲
    Chief Executive OfficerExecutives
    19,992 GBP25RNS
    13,328 shares@ £1.5030.7% of flowLondon Stock Exchange, AIM Market (XLON)RNS:5369478
    Canonical exit: 26 Dec 2024 (T+90)

9 of 9 declarations

About Optima Health plc

Optima Health plc is a publicly traded company on the London Stock Exchange, specializing in the healthcare sector. It offers various health and wellness services and solutions.